Signal #1 - Improved Company Revenue Prediction
PharmaKB data is used to build an improved model (left panel) for predicting company revenues.*
* Results are based on retrospective data and may vary in any future trades.
Signal #2 - Portfolio Building with Alternative Drug Data
Alternative drug data provides a signal to build a biotech portfolio
with higher performing cumulative revenues
than less preferred companies and a Biotech ETF (XBI).*
* Results are based on retrospective data and may vary in any future trades.
Signal #3 - Portfolio Building with Alternative Drug Data
Alternative drug data provides a signal to build a biotech portfolio
with higher performing cumulative revenues
than less preferred companies and a Biotech ETF (XBI).*
* Results are based on retrospective data and may vary in any future trades.
Signal #4 - Portfolio Building with Alternative Drug Data
Alternative drug data provides a signal to build a biotech portfolio
with higher performing cumulative revenues
than less preferred companies and a Biotech ETF (XBI).*
* Results are based on retrospective data and may vary in any future trades.
Signal #5 - Predicting Market Shares
Alternative drug data provides a signal to build a biotech portfolio
to select companies with higher predicted share growth
than less preferred companies and a Biotech ETF (XBI).*
* Results are based on retrospective data and may vary in any future trades.
Signal #6 - Trading Drug Regulatory Signals
Model for trading drug regulatory event signals generates $350 million in capital accumulation,
starting from a $1 million investment over 30 years.*
* Results are modeled on retrospective data and may vary in any future trades.
Signal #7 - Created by AltHub (3rd Party) using PharmaKB
AltHub (3rd Party) uses a PharmaKB signal to build a biotech portfolio (yellow) with higher returns than the IBB Biotech ETF (orange).*
* Results are based on retrospective data and may vary in any future trades.